← Leaderboards
Carmen C Sucharov
University Of Colorado Denver
$5,015,125
Attributed
$12,605,022
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2007–25$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,605,022 · 8
By mechanism
R01$10,856,092 · 4
K01$646,058 · 1
K24$536,785 · 1
R21$412,556 · 1
R41$153,531 · 1
Top collaborators
- Shelley Deanne Miyamoto16 shared
- Brian L Stauffer11 shared
- Steven Edward Lipshultz5 shared
- Todd C Carpenter4 shared
- Eva Nozik Grayck4 shared
- Uday B Kompella4 shared
- Sarah Faubel2 shared
- Ling Shi2 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Shelley Deanne Miyamoto$5,520,361
- Brian L Stauffer$5,871,842
- Robin Shandas$12,521,834
- Mehdi Hedjazi Moghari$2,000,668
- Jesse Davidson$4,139,957
Others in their field
Top investigators on “Heart Failure”
- Judith S Hochman · New York University School Of Medicine$120,321,606
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$51,947,333
- Lisa P Jacobson · Johns Hopkins University$45,397,923
- Walter N Kernan · Yale University$42,197,025
- Dalane W Kitzman · Wake Forest University$40,701,149
- David Couper · Univ Of North Carolina Chapel Hill$37,959,091
Research focus
Heart FailureHeartChildhoodAdultSerumMolecularPublishingResponseSignal TransductionTissuesInvestigationTransplantationNeonatalGene ExpressionCardiacBaseMediatingFunctional DisorderCardiac MyocytesVentricularMyocardiumMedicalMitochondriaMicrornas
Grant awards (33)
Targeting Mitochondria in Single Ventricle Heart Disease$650,943
R01 · FY2025 · HL
Targeting Mitochondria in Single Ventricle Heart Disease$651,604
R01 · FY2024 · HL
Investigations of Pathologic Remodeling Using Pediatric Heart Failure Serum$106,046
K24 · FY2024 · HL · contact PI
Targeting Mitochondria in Single Ventricle Heart Disease$87,104
R01 · FY2024 · HL
Targeting Mitochondria in Single Ventricle Heart Disease$675,629
R01 · FY2023 · HL
Targeting Mitochondria in Single Ventricle Heart Disease$161,134
R01 · FY2023 · HL
Investigations of Pathologic Remodeling Using Pediatric Heart Failure Serum$106,674
K24 · FY2023 · HL · contact PI
Targeting Mitochondria in Single Ventricle Heart Disease$686,049
R01 · FY2022 · HL
Cardiac dysfunction after ischemic AKI in mice$592,494
R01 · FY2022 · HL
Targeting Mitochondria in Single Ventricle Heart Disease$161,134
R01 · FY2022 · HL
Investigations of Pathologic Remodeling Using Pediatric Heart Failure Serum$107,361
K24 · FY2022 · HL · contact PI
Prognostic Significance of microRNA Expression in Children with Cardiomyopathy$799,064
R01 · FY2021 · HL
Targeting Mitochondria in Single Ventricle Heart Disease$723,914
R01 · FY2021 · HL
Cardiac dysfunction after ischemic AKI in mice$592,494
R01 · FY2021 · HL
Investigations of Pathologic Remodeling Using Pediatric Heart Failure Serum$108,028
K24 · FY2021 · HL · contact PI
Targeting mitochondria in SV heart disease$76,211
R01 · FY2021 · HL
Prognostic Significance of microRNA Expression in Children with Cardiomyopathy$800,404
R01 · FY2020 · HL
Investigations of Pathologic Remodeling Using Pediatric Heart Failure Serum$108,676
K24 · FY2020 · HL · contact PI
Prognostic Significance of microRNA Expression in Children with Cardiomyopathy$898,361
R01 · FY2019 · HL
Prognostic Significance of microRNA Expression in Children with Cardiomyopathy$795,301
R01 · FY2018 · HL
Prognostic Significance of microRNA Expression in Children with Cardiomyopathy$47,571
R01 · FY2018 · HL
miRNA Regulation of Vascular Permeability and Inflammation in the Lung Injury$618,741
R01 · FY2017 · HL
Non-invasive risk assessment tool for pediatric heart failure$153,531
R41 · FY2017 · HL · contact PI
miRNA Regulation of Vascular Permeability and Inflammation in the Lung Injury$614,883
R01 · FY2016 · HL
miRNA Regulation of Vascular Permeability and Inflammation in the Lung Injury$602,207
R01 · FY2015 · HL
miRNA Regulation of Vascular Permeability and Inflammation in the Lung Injury$620,850
R01 · FY2014 · HL
Mechanisms of YY1 Inhibition of Cardiac Hypertrophy$136,950
K01 · FY2011 · HL · contact PI
Cardiac Beta-Adrenergic Adaptation in Pediatric Heart Failure$223,356
R21 · FY2010 · HL
Mechanisms of YY1 Inhibition of Cardiac Hypertrophy$132,930
K01 · FY2010 · HL · contact PI
Cardiac Beta-Adrenergic Adaptation in Pediatric Heart Failure$189,200
R21 · FY2009 · HL
Mechanisms of YY1 Inhibition of Cardiac Hypertrophy$129,063
K01 · FY2009 · HL · contact PI
Mechanisms of YY1 Inhibition of Cardiac Hypertrophy$125,346
K01 · FY2008 · HL · contact PI
Mechanisms of YY1 Inhibition of Cardiac Hypertrophy$121,769
K01 · FY2007 · HL · contact PI